Literature DB >> 12618340

RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats.

Li Ma1, Rebecca J Carter, A Jennifer Morton, Louise F B Nicholson.   

Abstract

The receptor for advanced glycation end products (RAGE) is a multi-ligand member of the immunoglobulin superfamily of cell surface molecules. The RAGE-ligand interaction has a putative role in a range of chronic disorders and is also known to contribute to both inflammatory/degenerative processes as well as regeneration in peripheral nerve injury. We have investigated the expression of RAGE in the moderate hypoxic-ischemic (HI) rat brain injury model in order to determine if this receptor is involved in the cellular perturbation mediated by ischemic stress. RAGE mRNA levels were detected by in situ hybridization using a DIG-labelled 48 mer oligonucleotide probe. Results showed a high level of expression of RAGE mRNA in the CA1/2 pyramidal cell layer of the hippocampus on the lesioned side of the brain 72 h after a moderate hypoxic-ischemic insult. RAGE was not expressed on the control side of the hippocampus. The RAGE-positive cells had a unique morphology, being angular in shape and atrophied with a condensed cell nucleus. They were NeuN-positive and were identified as dying cells by staining with thionin/acid fuchsin. A subset of cells was positive for cleaved Caspase-3, a marker for apoptosis. Together these data show that RAGE is expressed in dying neurons and suggest that RAGE may have a role in neuronal cell death mediated by ischemic stress. Identification of the ligand for RAGE in the ischemic brain may lead to a better understanding of RAGE-mediated cellular dysfunction in the CNS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618340     DOI: 10.1016/s0006-8993(02)04149-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head.

Authors:  Gülgün Tezel; Cheng Luo; Xiangjun Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

2.  Modulation of RAGE isoforms expression in the brain and plasma of rats exposed to transient focal cerebral ischemia.

Authors:  Rosaria Greco; Diana Amantea; Antonina Stefania Mangione; Francesco Petrelli; Rocco Gentile; Giuseppe Nappi; Fabio Blandini; M Tiziana Corasaniti; Cristina Tassorelli
Journal:  Neurochem Res       Date:  2012-04-19       Impact factor: 3.996

3.  Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism.

Authors:  Cátia Monteiro; Lauritz Miarka; María Perea-García; Neibla Priego; Pedro García-Gómez; Laura Álvaro-Espinosa; Ana de Pablos-Aragoneses; Natalia Yebra; Diana Retana; Patricia Baena; Coral Fustero-Torre; Osvaldo Graña-Castro; Kevin Troulé; Eduardo Caleiras; Patricia Tezanos; Pablo Muela; Elisa Cintado; José Luis Trejo; Juan Manuel Sepúlveda; Pedro González-León; Luis Jiménez-Roldán; Luis Miguel Moreno; Olga Esteban; Ángel Pérez-Núñez; Aurelio Hernández-Lain; José Mazarico Gallego; Irene Ferrer; Rocío Suárez; Eva M Garrido-Martín; Luis Paz-Ares; Celine Dalmasso; Elizabeth Cohen-Jonathan Moyal; Aurore Siegfried; Aisling Hegarty; Stephen Keelan; Damir Varešlija; Leonie S Young; Malte Mohme; Yvonne Goy; Harriet Wikman; Jose Fernández-Alén; Guillermo Blasco; Lucía Alcázar; Clara Cabañuz; Sergei I Grivennikov; Andrada Ianus; Noam Shemesh; Claudia C Faria; Rebecca Lee; Paul Lorigan; Emilie Le Rhun; Michael Weller; Riccardo Soffietti; Luca Bertero; Umberto Ricardi; Joaquim Bosch-Barrera; Elia Sais; Eduard Teixidor; Alejandro Hernández-Martínez; Alfonso Calvo; Javier Aristu; Santiago M Martin; Alvaro Gonzalez; Omer Adler; Neta Erez; Manuel Valiente
Journal:  Nat Med       Date:  2022-04-11       Impact factor: 87.241

4.  Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process.

Authors:  Hao-Liang Xu; Francesco Vetri; Hae-Kyung Lee; Shuhua Ye; Chanannait Paisansathan; Lizhen Mao; Fulong Tan; Dale A Pelligrino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-09       Impact factor: 4.733

5.  Effect of transient cerebral ischemia on the expression of receptor for advanced glycation end products (RAGE) in the gerbil hippocampus proper.

Authors:  Jae-Chul Lee; Jun Hwi Cho; Geum-Sil Cho; Ji Hyeon Ahn; Joon Ha Park; In Hye Kim; Jeong-Hwi Cho; Hyun-Jin Tae; Seung Hwan Cheon; Ji Yun Ahn; Jinseu Park; Soo Young Choi; Moo-Ho Won
Journal:  Neurochem Res       Date:  2014-06-01       Impact factor: 3.996

6.  Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes.

Authors:  John B Redell; Yin Liu; Pramod K Dash
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

7.  Increased expression of receptor for advanced glycation end-products worsens focal brain ischemia in diabetic rats.

Authors:  Ying Xing; Jinting He; Weidong Yu; Lingling Hou; Jiajun Chen
Journal:  Neural Regen Res       Date:  2012-05-05       Impact factor: 5.135

8.  Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice.

Authors:  Seiichi Sakatani; Kazuyuki Yamada; Chihiro Homma; Seiichi Munesue; Yasuhiko Yamamoto; Hiroshi Yamamoto; Hajime Hirase
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

9.  Levels of Soluble Receptor for Advanced Glycation End Products in Acute Ischemic Stroke without a Source of Cardioembolism.

Authors:  Hyun-Young Park; Kyeong Ho Yun; Do-Sim Park
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077

10.  Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.

Authors:  Rui Liu; Cai-Xia Wu; Dan Zhou; Fan Yang; Shuo Tian; Li Zhang; Tian-Tai Zhang; Guan-Hua Du
Journal:  BMC Med       Date:  2012-09-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.